Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $35.11B | $577.89 | -1.51% | $114.32M | 38.19x | 0.13 | Belgium | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $987.53M | $14.56 | -2.02% | $17.67M | 56.00x | 0.30 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $749.12M | $7.99 | -0.99% | $13.36M | 99.88x | 0.37 | United States | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $5.72B | $36.01 | -3.64% | $70.41M | 133.37x | 1.77 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.43B | $70.06 | -1.57% | $110.98M | 55.17x | 0.24 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $19.59B | $34.84 | -1.22% | $1.34B | 14.11x | 0.80 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $2.15B | $42.67 | 0.45% | $16.81M | 853.40x | 0.44 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $3.96B | $137.07 | -2.32% | $144.76M | 31.73x | 0.09 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.11B | $8.18 | -0.61% | $65.88M | 28.21x | 0.44 | Canada | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.89B | $32.97 | -1.08% | $237.95M | 12.35x | 0.47 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $6.65B | $53.98 | -1.03% | $704.60M | 14.02x | 3.56 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.87B | $23.53 | -3.13% | $296.55M | 14.26x | 0.14 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $13.11B | $67.75 | -2.12% | $406.83M | 233.62x | 0.57 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.97B | $20.81 | -3.66% | $160.80M | 23.65x | 0.37 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.13B | $3.71 | -3.13% | $82.59M | 37.10x | -8.00 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.34B | $41.59 | -0.45% | $894.63M | 18.48x | 0.33 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $356.44B | $79.83 | -1.51% | $23.12B | 22.37x | 2.53 | Denmark | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $892.12M | $6.04 | -1.31% | $63.32M | 22.37x | 0.33 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $7.92B | $50.52 | -1.96% | $289.57M | 60.87x | 0.31 | United States | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $6.69B | $108.50 | -1.63% | $1.25B | 13.93x | 1.76 | Ireland | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.07B | $26.44 | -0.94% | $63.03M | 61.49x | 0.10 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.78B | $56.22 | -1.85% | $777.43M | 20.44x | 0.23 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $1.07B | $13.63 | -3.61% | $16.04M | 75.72x | 0.47 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $15.11B | $22.82 | -1.17% | N/A | 13.17x | 0.24 | Denmark | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.63B | $21.71 | -0.14% | $278.16M | 15.73x | 0.48 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.